Bone Biologics
BBLG
Bone Biologics (BBLG) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$1.33
- EPS estimate
- −$0.58
- EPS surprise
- −129.31%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 14, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 14, 2025 | −$0.58 | −$1.33 | −129.31% | $0.00 | SEC |
| Q1 2025 | May 12, 2025 | −$3.24 | −$0.32 | +90.12% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$7.86 | −$7.86 | +0.00% | $0.00 | SEC |
| Q4 2023 | Feb 21, 2024 | −$282.72 | −$35.34 | +87.50% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$29.28 | −$29.28 | +0.00% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$81.12 | −$81.12 | +0.00% | $0.00 | SEC |
| Q1 2022 | May 13, 2022 | −$288.00 | −$100.80 | +65.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Bone Biologics (BBLG) last report earnings?
Bone Biologics last reported on Aug 14, 2025, covering fiscal Q2 2025.
Did BBLG beat earnings estimates?
No. Bone Biologics reported EPS of −$1.33 for Q2 2025 against a −$0.58 estimate — a 129.31% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.